BioCentury
ARTICLE | Company News

Xencor names King chairman

March 20, 2008 1:24 AM UTC

Autoimmune and cancer company Xencor (Monrovia, Calif.) appointed David King chairman. Previously, he was CEO of BioRexis, which was acquired by Pfizer (NYSE:PFE) last year. ...